IDEAYA Biosciences (NASDAQ: IDYA) reported Q1 EPS of ($1.11), $0.12 worse than the analyst estimate of ($0.99). Revenue for the quarter came in at $6.56 million versus the consensus estimate of $5.19 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.